Joint Heidelberg-IDC Translational Diabetes Program
Collaborative Research Center 1118
Collaborative Research Center 1118
About our research
The Joint Heidelberg-IDC Translational Diabetes Unit represents the translational and clinical arm of the IDC Diabetes activities and has been established in collaboration with the University Hospital Heidelberg, Germany, and the Collaborative Research Center 1118, funded by the Deutsche Forschungsgemeinschaft DFG.
This unit is co-directed by Peter Nawroth, Clinical director of the Inner Medicine I department at Heidelberg University Hospital, and IDC director Stephan Herzig and offers the opportunity to directly transfer findings from the IDC research divisions into clinical practice.
A particular focus is placed on therapies geared towards the remission of diabetes long-term complications and combinatorial therapies against conditions of chronic malnutrition, supported by both patient-derived biobanks and clinical trials.
Medical Director of the Clinic for Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry at Heidelberg University Hospital
Head of "Joint IDC-Heidelberg Translational Diabetes Program"
Postdoc
Technische Assistentin
Our Most Recent Publications
Yıldırım, S. ; Mhamane, A. ; Lösch, S. ; Wieder, A. ; Ermis, E. ; König, A.-C. ; Yilmaz, S. ; Hauck, S.M. ; Kocabaş, F. ; Szendroedi, J. ; Herzig, S. ; Ekim Üstünel, B.
TSC22D1 is a newly identified inhibitor of insulin secretion in pancreatic beta cells.Lorza-Gil, E. ; Ekim Üstünel, B. ; Sancar, G.
Editorial: Organ crosstalk in the pathophysiology and treatment of type-2 diabetes.De Angelis Rigotti, F. ; Wiedmann, L. ; Hubert, M.O. ; Vacca, M. ; Hasan, S.S. ; Moll, I. ; Carvajal, S. ; Jiménez, W. ; Starostecka, M. ; Billeter, A.T. ; Müller-Stich, B. ; Wolff, G. ; Ekim Üstünel, B. ; Herzig, S. ; Fandos-Ramo, C. ; Krätzner, R. ; Reich, M. ; Keitel-Anselmino, V. ; Heikenwälder, M. ; Mogler, C. ; Fischer, A. ; Rodriguez-Vita, J.
Semaphorin 3C exacerbates liver fibrosis.Contact Us